Anticorps Monoclonal anti-Alpha 1 antichymotrypsin

Alpha 1 antichymotrypsin Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, porc

Applications

WB, IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

3F2F10

N° de cat : 66078-1-PBS

Synonymes

Alpha Antichymotrypsin, SERPINA3, ACT, AACT, A-1-Antichymotrypsin



Informations sur le produit

66078-1-PBS cible Alpha 1 antichymotrypsin dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc

Réactivité Humain, porc
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène Alpha 1 antichymotrypsin Protéine recombinante Ag2830
Nom complet serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
Masse moléculaire calculée 448 aa, 48 kDa
Poids moléculaire observé 60 kDa
Numéro d’acquisition GenBankBC010530
Symbole du gène Alpha 1 Antichymotrypsin
Identification du gène (NCBI) 12
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Human SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a member of the serine protease inhibitor class, and is a plasma alpha globulin glycoprotein which increases in the blood during the inflammatory process. SerpinA3, is also an inhibitor of neutrophil cathepsin G, mast cell chymases and pancreatic chymotrypsin. SerpinA3 is produced primarily in the liver, and is identified as an acute-phase inflammatory protein. SerpinA3 deficiency has been associated with liver disease. SerpinA3 has also been implicated in the pathology of a number of devastating human diseases including chronic obstructive pulmonary disease (COPD), Parkinson's disease (PD), Alzheimer's disease (AD), Stroke, Cystic Fibrosis, Cerebral Haemorrhage and Multiple System Atrophy.

{{ptg:RelatedPrimaryAntibodies}}